( in Million)
Particulars
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
375.7
374.7
630.9
1004.3
Total Expenditure
342.3
283.4
640.7
1016.1
PBIDT (Excl OI)
33.4
91.3
-9.80
-11.80
Other Income
53.7
60.2
79.3
36.6
Operating Profit
87.1
151.5
69.50
24.80
Interest
148.3
132.2
138.3
110.8
Exceptional Items
-113.5
-58.5
-114
NA
PBDT
-174.7
-39.2
-182.8
-85.99
Profit Before Tax
-185.7
-50.2
-194
-96.59
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-185.8
-50.2
-280.4
-94.19
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-185.8
-50.2
-280.4
-94.19
Minority Interest
0.6
0.6
2.1
0.6
Shares of Associates
0.2
-0.1
-4.5
-0.1
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-185
-49.7
-282.8
-93.7
Equity Capital
664.1
664.1
648.6
648.6
Calculated EPS
-0.55
-0.14
-0.87
-0.28
Calculated EPS (Annualised)
-2.22
-0.59
-3.48
-1.15
No of Public Share Holdings
107128887
107128887
107128887
107128887
% of Public Share Holdings
32.29
32.29
33.06
33.06
PBIDTM% (Excl OI)
8.89
24.36
-1.55
-1.17
PBIDTM%
23.18
40.43
11.01
2.46
PBDTM%
-46.49
-10.46
-28.97
-8.56
PBTM%
-49.42
-13.39
-30.74
-9.61
PATM%
-49.45
-13.39
-44.44
-9.37